Loading...
Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18–64 years in the USA
INTRODUCTION: Intravenous tissue plasminogen activator (IV tPA) is a globally recommended treatment for patients with acute ischaemic stroke. We examined IV tPA use among patients aged 18–64 years with a primary diagnosis of acute ischaemic stroke in the USA and inpatient costs per hospitalisation b...
Saved in:
| Published in: | Stroke Vasc Neurol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990217/ https://ncbi.nlm.nih.gov/pubmed/27547449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2015-000002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|